Peptide Library / Mind & Mood
Selank
Also known as: TP-7 (tuftsin analog)
A Russian-developed anti-anxiety peptide — studied for calming without sedation, and without the dependence profile of benzodiazepines.
| Typical research dose | 250–500 mcg (injectable) or 300–900 mcg (nasal) |
|---|---|
| Frequency | 1–2× daily as needed |
| Route | Nasal spray or subcutaneous injection |
| Cycle length | 2–4 weeks on, break, repeat as needed |
Figures reflect protocols commonly reported in the research community — not a prescription or a recommendation.
What it is
Selank is a synthetic analog of tuftsin, an immune-related peptide, developed by Russian institutes and used clinically there for anxiety disorders. It's studied for anxiolytic (anti-anxiety) effect that arrives without sedation, motor impairment, or the tolerance/dependence pattern of benzodiazepines.
What the research looks at
- Anxiety — Russian clinical trials report benzodiazepine-comparable anxiety reduction in generalized anxiety, without the hangover profile.
- Cognition under stress — improved attention and memory in stressed subjects; it modulates BDNF (a growth factor for neurons).
- Immune modulation — its tuftsin parentage; enkephalin degradation slows too.
- What's missing — Western replication; nearly all human data is from Russian literature.
How protocols are commonly structured
Nasal is the traditional route (the Russian product is a nasal drop): 300–900 mcg per day, split. Injectable protocols run 250–500 mcg once or twice daily. It's commonly used situationally (high-stress periods) in 2–4 week runs rather than continuously. Often discussed alongside Semax — Selank for calm, Semax for drive.
Reconstitution & storage
Lyophilized powder; bacteriostatic water for injectable use (calculator); sterile saline for nasal-spray preparations. Refrigerate after mixing.
Research protocols, not a prescription — talk to a physician before touching anything.